Abstract
Urinary liver-type fatty-acid-binding protein (L-FABP) is a useful clinical marker in the monitoring of chronic kidney disease (CKD) associated with tubulointerstitial damage. Statins have been shown to be effective in the treatment of renal disease. The aim of the present study was to determine whether pitavastatin, a newly developed statin, modulates the urinary L-FABP levels in normolipidemic patients with CKD. Thirty normolipidemic mild CKD patients (18 males and 12 females, mean age 40 years, mean serum creatinine level 1.0 mg/dl) were randomly assigned to two groups: (1) pitavastatin (1 mg/day, n = 15) and (2) placebo (n = 15). Urinary protein and urinary L-FABP levels were measured before the initiation of treatment and 3 and 6 months thereafter. Twenty age-matched healthy subjects were also studied as controls. Before treatment, the urinary L-FABP levels in 30 CKD patients (84.0 +/- 68.5 microg/g creatinine) were significantly higher than those of healthy subjects (6.4 +/- 4.2 mug/g creatinine; p < 0.001). Pitavastatin slightly reduced serum total cholesterol and triglyceride levels, but this was not statistically significant. However, pitavastatin reduced the urinary protein excretion from 1.8 to 1.0 g/day (p < 0.01), ...Continue Reading
References
Nov 15, 1992·The Biochemical Journal·R G MaatmanJ H Veerkamp
Nov 5, 1997·Kidney International·F VrtovsnikG Friedlander
Jan 3, 2001·Kidney International·L F FriedB L Kasiske
May 1, 2002·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Tsukasa NakamuraHikaru Koide
Aug 22, 2003·Cardiovascular Drug Reviews·Kouji KajinamiYasushi Saito
Oct 2, 2003·American Journal of Physiology. Renal Physiology·Can LiByung Kee Bang
Feb 18, 2004·Internal Medicine·Masaomi Nangaku
Sep 2, 2004·Journal of the American Society of Nephrology : JASN·Anja VerhulstMarc E De Broe
Oct 7, 2004·The American Journal of Pathology·Atsuko KamijoKenjiro Kimura
Feb 8, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Murray Epstein, Vito M Campese
Apr 15, 2005·Clinical and Experimental Nephrology·Toshihiko IshimitsuHiroaki Matsuoka
Apr 28, 2005·International Journal of Clinical Practice·R Y A MukhtarJ P D Reckless
May 6, 2005·The Journal of Laboratory and Clinical Medicine·Atsuko KamijoKenjiro Kimura
Jun 23, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Toshiki HimedaTsutomu Araki
Jan 25, 2006·Clinical Nephrology·T NakamuraH Koide
Citations
May 24, 2007·Diabetologia·J WeiY M Li
Jul 1, 2010·Cardiovascular Intervention and Therapeutics·Tsuyoshi NozueIchiro Mizuguchi
Dec 2, 2010·Journal of Hypertension·Xian Wu ChengToyoaki Murohara
Jul 23, 2009·BMC Cancer·Angelika TölleGlen Kristiansen
Dec 10, 2009·Vascular Health and Risk Management·Yasushi Saito
Dec 4, 2010·Vascular Health and Risk Management·Jun Sasaki
Oct 16, 2008·Clinical and Experimental Hypertension : CHE·Tsukasa NakamuraKoichi Node
Feb 23, 2013·Current Medical Research and Opinion·Dragana NikolicUNKNOWN Lipid and Blood Pressure Meta-Analysis Collaboration Group
Jun 16, 2007·The American Journal of the Medical Sciences·Tsukasa NakamuraKoichi Node
Feb 26, 2016·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Xiaole SuHong Zhang
Jun 24, 2011·Kidney International·Robert G FassettWendy E Hoy
Dec 5, 2008·Transplant International : Official Journal of the European Society for Organ Transplantation·Adrian LiewAnantharaman Vathsala
Nov 8, 2011·British Journal of Clinical Pharmacology·Jean Davignon
Jul 25, 2006·Clinica Chimica Acta; International Journal of Clinical Chemistry·Atsuko Kamijo-IkemoriKenjiro Kimura
Apr 15, 2016·Future Cardiology·Vivencio Barrios, Carlos Escobar
Sep 11, 2013·International Journal of Cardiology·Dragana NikolicUNKNOWN Lipid and Blood Pressure Meta-Analysis Collaboration Group
Jun 1, 2014·The Cochrane Database of Systematic Reviews·Suetonia C PalmerGiovanni F M Strippoli
Mar 31, 2011·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Pedro Marques da Silva
Jun 20, 2020·The Cochrane Database of Systematic Reviews·Stephen P AdamsJames M Wright
Nov 13, 2013·Expert Review of Cardiovascular Therapy·Vivencio BarriosJosé L Zamorano
Feb 24, 2012·Drugs·Sean T Duggan
Aug 21, 2008·Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum·Maurice M A L Pelsers
May 1, 2021·Renal Failure·Lin ZhaoYing Gao